ArticleTrials2025

Antisecretory factor in severe traumatic brain injury (AFISTBI): protocol for an exploratory randomized placebo-controlled trial.

Linus Réen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.